Correction to: Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years by Muller I, Willis M, Healy S, Nasser T, Loveless S, Butterworth S, Zhang L, Draman MS, Taylor PN, Robertson N, Dayan CM, and Ludgate ME. Thyroid 2018;28:1682–1693. DOI: 10.1089/thy.2018.0232

Thyroid, Volume 29, Issue 2, Page 309-309, February 2019.


from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader http://bit.ly/2tmIUBG